Sullivan, Bruyette, Speros & Blaney’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $337K | Sell |
5,220
-191
| -4% | -$12.3K | 0.01% | 224 |
|
|
2020
Q4 | $315K | Buy |
5,411
+131
| +2% | +$7.63K | 0.01% | 221 |
|
|
2020
Q3 | $334K | Sell |
5,280
-1,012
| -16% | -$64K | 0.02% | 189 |
|
|
2020
Q2 | $484K | Sell |
6,292
-2,211
| -26% | -$170K | 0.03% | 140 |
|
|
2020
Q1 | $636K | Buy |
8,503
+2,075
| +32% | +$155K | 0.04% | 106 |
|
|
2019
Q4 | $418K | Sell |
6,428
-130
| -2% | -$8.45K | 0.02% | 155 |
|
|
2019
Q3 | $416K | Sell |
6,558
-178
| -3% | -$11.3K | 0.02% | 151 |
|
|
2019
Q2 | $455K | Buy |
6,736
+959
| +17% | +$64.8K | 0.03% | 137 |
|
|
2019
Q1 | $376K | Buy |
5,777
+3
| +0.1% | +$195 | 0.02% | 149 |
|
|
2018
Q4 | $361K | Buy |
5,774
+441
| +8% | +$27.6K | 0.02% | 135 |
|
|
2018
Q3 | $412K | Sell |
5,333
-66
| -1% | -$5.1K | 0.04% | 109 |
|
|
2018
Q2 | $382K | Hold |
5,399
| – | – | 0.04% | 113 |
|
|
2018
Q1 | $407K | Sell |
5,399
-774
| -13% | -$58.3K | 0.04% | 102 |
|
|
2017
Q4 | $442K | Buy |
6,173
+84
| +1% | +$6.02K | 0.04% | 98 |
|
|
2017
Q3 | $493K | Sell |
6,089
-5
| -0.1% | -$405 | 0.05% | 87 |
|
|
2017
Q2 | $431K | Sell |
6,094
-453
| -7% | -$32K | 0.04% | 91 |
|
|
2017
Q1 | $445K | Sell |
6,547
-232
| -3% | -$15.8K | 0.04% | 85 |
|
|
2016
Q4 | $485K | Buy |
6,779
+42
| +0.6% | +$3.01K | 0.05% | 85 |
|
|
2016
Q3 | $533K | Buy |
6,737
+257
| +4% | +$20.3K | 0.05% | 74 |
|
|
2016
Q2 | $541K | Buy |
+6,480
| New | +$541K | 0.06% | 66 |
|